Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of sodium borocaptate with or without blood- brain barrier disruption

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 3, 1997, Pages 663-672

  Yang, Weilian ^a   Barth, Rolf F ^a   Rotaru, Joan H ^a   Moeschberger, Melvin L ^a   Joel, Darrel D ^b   Nawrocky, Marta M ^b   Goodman, Joseph H ^a   Soloway, Albert H ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Blood brain barrier disruption; Boron neutron capture therapy; Intracarotid injection; Rat glioma; Sodium borocaptate

Indexed keywords

BOROCAPTATE; BORON DERIVATIVE; ETHYLNITROSOUREA; MANNITOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER SURVIVAL; CAROTID ARTERY; CONTROLLED STUDY; DRUG DISTRIBUTION; GLIOMA; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030900821     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00082-X     Document Type: Article

References (56)

1. Abe, M.; Amano, K.; Kitamura, K.; Ohta, M.; Tateishi, J.; Hatanaka, H. Capillary permeability and boron distribution in ethyl nitrosourea-induced rat glioma. Neurosurgery 22:23-31; 1988.
2. Barth, R. F.; Soloway, A. H.; Brugger, R. M. Boron neutron capture therapy of brain tumors: Past history, current status and future potential. Cancer Invest. 6:534-560; 1996.
3. Barth, R. F.; Adams, D. M.; Soloway, A. H.; Mechetner, E. B.; Alam, F.; Anisuzzaman, A. K. M. Determination of boron in tissues and cells using direct-current plasma atomic emmission spectroscopy. Analyt. Chem. 63:890-893; 1991.
4. Barth, R. F.; Yang, W.; Rotaru, J. H.; Moeschberger, M. L.; Joel, D. D.; Nawrocky, M. M.; Goodman, J. H.; Soloway, A. H. Boron neuron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood brain barrier disruption. Cancer Res. 57:1129-1136; 1997.
5. Ceberg, C. P.; Brun, A.; Mir, L. M.; Persson, B. R. R.; Salford, L. G. Enhanced boron uptake in RG2 rats gliomas by electropermeabilization in vivo - A new possibility in boron neutron capture therapy. Anticancer Drugs 5:463-466; 1994.
6. Ceberg, C. P.; Brun, A.; Kahl, S. B.; Koo, M. S.; Persson, B. R. R.; Salford, L. G. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. J. Neurosurg. 83:86-92; 1995.
7. Ceberg, C. P.; Persson, A.; Brun, A.; Huiskamp, R.; Fyhr, A.; Persson, B. R. R.; Salford, L. G. Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: A basis for boron neutron capture therapy. J. Neurosurg. 83:79-85; 1995.
8. Clendenon, N. R.; Barth, R. F.; Gordon, W. A.; Goodman, J. H.; Alam, F.; Staubus, A. E.; Boesel, C. P.; Yates, A. J.; Moeschberger, M. L.; Fairchild, R. G.; Kalef-Ezra, J. A. Boron neutron capture therapy of a rat glioma. Neurosurgery 26:47-55; 1990.
9. Coderre, J. A.; Button, T. M.; Micca, P. L.; Fisher, C. D.; Nawrocky, M. M.; Liu, H. B. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int. J. Radiat. Oncol. Biol. Phys. 30:643-652; 1994.
10. Coderre, J. A.; Joel, D. D.; Micca, P. L.; Nawrocky, M. M.; Slatkin, D. N. Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine. Radiat. Res. 129:290-296; 1992.
11. Eckman, W. W.; Patlak, C. S.; Fenstermacher, J. D. A critical evaluation of the principles governing the advantage of infraarterial infusions. J. Pharmacokinet. Biopharm. 2:257-285: 1974.
12. Fairchild, R. G.; Kalef-Ezra, J. A.; Fiarman, S.; Wielopolski, L.; Hanz, J.; Mussolino, S.; Wheeler, F. Optimization of an epithermal beam for NCT at Brookhaven Medical Research Reactor (BMRR). Strahlenther. Onkol. 165:215-217; 1989.
13. Fairchild, R. G.; Slatkin, D. N.; Coderre, J. A.; Micca, P. L.; Laster, B. H.; Kahl, S. B.; Som, P.; Fand, I.; Wheeler, F. Optimization of boron and neutron delivery for neutron capture therapy. Pigment Cell Res. 2:309-318; 1989.
14. Fenstermacher, C. D.; Cowles, A. L. Theoretic limitation of intracarotid infusion in brain tumor chemotherapy. Cancer Treat. Rep. 61:519-526; 1977.
15. Fenstermacher, C. D. Intra-arterial infusion of drugs and hyperosmotic solutions as way of enhancing CNS chemotherapy. Cancer Treat. Rep. 65:27-37; 1981.
16. Gabel, D.; Moss, R., eds. Boron neutron capture therapy: Toward clinical trials of glioma treatment. New York: Plenum Press; 1992.
17. Goodman, J. H.; McGregor, J. M.; Clendenon, N. R.; Gahbauer, R. A.; Barth, R. F.; Soloway, A. H.; Fairchild, R. G. Inhibition of tumor growth in a glioma model treated with boron neutron capture therapy. Neurosurgery 27:383-388; 1990.
18. Greig, N. H. Drug delivery to the brain by blood-brain barrier circumvention and drug modification. In: Neuwelt, A. E., ed. Implications of the blood-brain barrier and its manipulation. New York: Plenum Press; 1994:311-357.
19. Groothuis, D. R.; Fischer, J. M.; Vick, N. A.; Bigner, D. D. Comparative permeability of different glioma models to horseradish peroxidase. Cancer Treat. Rep. 65:13-18; 1981.
20. Gummerlock, M. K.; Neuwelt, E. A. Chemotherapy of brain tumors: Innovative approaches. In: Morantz, R. G.; Walsh, J. W.; Dekker, M., eds. Handbook of brain tumors. New York: Plenum Press; 1993:763-778.
21. 11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT). Int. J. Radiat. Oncol. Biol. Phys. 28:1175-1181; 1994.
22. 11SH in patients with glioblastoma. Cancer Res. 54:6318-6320; 1994.
23. 11SH. J. Neurosurg. 81:741-744; 1994.
24. Hatanaka, H.; Nakagawa, Y. Clinical results of long-survival brain tumor patients who underwent boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 28:1061-1066; 1994.
25. Hawthorne, M. H. The role of chemistry in the development of boron neutron capture therapy of cancer. Angew Chem. Int. Ed. Engl. 32:950-984; 1993.
26. Inamura, T.; Nomura, T.; Bartus, R. T.; Black, K. L. Intracarotid infusion of RMP-7, a bradykinin analogue: A method for selective drug delivery to brain tumors. J. Neurosurg. 81:752-758; 1994.
27. Jain, R. K. Barriers to drug delivery in solid tumors. Sci. Am. 271:58-65; 1994.
28. Joel, D. D.; Fairchild, R. G.; Laissue, J. A.; Saraf, S. K.; Kalef-Ezra, J. A.; Slatkin, D. N. Boron neutron capture therapy of intracerebral rat gliosarcomas. Proc. Natl. Acad. Sci. USA 87:9808-9812; 1990.
29. Joel, D. D.; Slatkin, D. N.; Micca, P. L.; Nawrock, M. M.; Doubois, T.; Velez, C. Uptake of boron into human gliomas of athymic mice and syngeneic cerebral glioma of rats after intracarotid infusion of sulfhydryl boranes. In: Fairchild, R. G.; Bond, V. P.; Woodhead, A. D., eds. Clinical aspects of neutron capture therapy. New York: Basic Life Sciences; 1989:325-333.
30. Kageji, T.; Matsumoto, K.; Nakagawa, Y.; Hatanaka, H. Pharmacokinetics and boron uptake of BSH in patients with intracranial tumors. J Neuro-Oncol. 32:117-130; 1997.
31. Kobayashi, N.; Allen, N.; Clendenon, N. R.; Ko, L. W. An improved rat brain-tumor model. J. Neurosurg. 53:808-815; 1980.
32. Ko, L.; Koestner, A.; Wechsler, W. Characterization of cell cycle and biological parameters of transplantable glioma cell lines and clones. Acta Neuropathol. 51:107-111; 1980.
33. Kraft, S.; Gavin, P. R.; Leathers, C. W.; Dehan, C. E.; Bauer, W. F.; Miller, D. L.; Dorn III, R. V.; Griebenow, M. L. Biodistribution of boron in dog with spontaneous intracranial tumors following borocaptate sodium administration. Cancer Res. 54:1259-1263; 1994.
34. Liu, L.; Barth, R. F.; Adams, D. M.; Soloway, A. H.; Reisfeld, R. A. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. Anticancer Research. 16:2581-2588; 1996.
35. Madsen, R. W.; Moeschberger, M. L., eds. Statistical concepts. Englewood Cliffs, NJ: Prentice-Hall; 1986.
36. Matalka, K. Z.; Bailey, M. Q.; Barth, R. F.; Staubus, A. E.; Moeschberger, M. L.; Coderre, A. J.; Rofstad, E. K. Boron neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent. Radiat. Res. 137:44-45; 1994.
37. Mishima, Y., ed. Cancer neutron capture therapy. New York: Plenum Press; 1996.
38. Miyagami, M.; Tsubokawa, T.; Tazoe, M.; Kagawa, Y. Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumor. Neurol. Med. Chir. (Tokyo) 30:582-590; 1990.
39. Neuwelt, E. A.; Barnett, P. A.; Hellström, K. E.; Hellström, I.; McCormick, C. I.; Ramsey, F. L. Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts. J. Nucl. Med. 35:1831-1841; 1994.
40. Neuwelt, E. A.; Barnett, P. A. Blood-brain barrier disruption in the treatment of brain tumors: Animal studies. In: Neuwelt, E. A., ed. Implications of the blood-brain barrier and its manipulation: Clinical implication, vol. 2. New York: Plenum Press 1989:107-194.
41. Neuwelt, E. A.; Frenkel, E. P. The challenge of the blood-brain barrier. In: Neuwelt, E. A., ed. Implications of the blood brain barrier and its manipulation. New York: Plenum Press; 1989:1-24.
42. Dahlborg, S. A.; Henner, W. D.; Crossen, J. R.; Tableman, M.; Petrillo, A.; Braziel, R.; Neuwelt, E. A. Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer Journal from Scientific American. 2:166-174; 1996.
43. Neuwelt, E. A.; Howieson, J.; Frenkel, E. P.; Specht, H. D.; Weigel, R.; Buchan, C.; Hill, S. A. Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood brain barrier modification in glioblastoma. Neurosurgery 19:573-582; 1986.
44. Nguyen, T.; Brownell, G. E.; Holden, S. A.; Kahl, S.; Miura, M. M.; Teicher, B. A. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capyure therapy by Monte Carlo simulations. Radiat. Res. 133:33-40; 1993.
45. Nomura, T.; Inamura, T.; Black, K. L. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res. 659:62-66; 1994.
46. Salcman, M.; Broadwell, R. D. The blood-brain barrier. In: Salcman, M., ed. Neurobiology of brain tumors. Baltimore: Williams & Wilkins; 1991:229-249.
47. Schuster, J. M.; Friedman, H. S.; Archer, G. E.; Fuchs, H. E.; McLendon, R. E.; Colvin, O. M.; Bigner, D. D. Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydro-peroxy-cyclophosphamide. Cancer Res. 53:2338-2343; 1993.
48. 7Li irradiation of the brain vasculature. Proc. Natl. Acad. Sci. USA 85:4020-4024; 1988.
49. Soloway, A. H.; Hatanaka, H.; Davis, M. A. Penetration of brain and brain tumor. VII tumor-binding sulfhydryl boron compounds. J. Med. Chem. 10:714-717; 1967.
50. Soloway, A. H.; Barth, R. F.; Carpenter, D. E., eds. Advances in neutron capture therapy. New York: Plenum Press; 1993.
51. Stragliotto, G.; Fankhauser, H. Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors. Neurosurgery 36:285-293; 1995.
52. Williams, P. C.; Henner, W. D.; Roman-Goldstein, S.; Dahlborg, S. A.; Brummet, R. E.; Tableman, M.; Dana, B.; Neuwelt, E. A. Toxicity and efficacy of carboplatin and etoposide in conjunction with blood-brain tumor barrier modification in the treatment of intracranial neoplasms. Neurosurgery 37:17-28; 1995.
53. Winer, B. J., ed. Statistical principles in experimental design. New York: McGraw-Hill Book Company; 1971.
54. Yang, W.; Barth, R. F.; Carpenter, D. E.; Moescherger, M.; Goodman, J. H. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption. Neurosurgery 38:985-992; 1996.
55. Yang, W.; Barth, R. F.; Rotaru, J. H.; Joel, D. D.; Nawrocky, M. M.; Goodman, J. H. Enhanced survival of F98 glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine. J Neuro-Oncology. 32:59-70; 1997.
56. Zamenhof, R.; Solares, G.; Harling, O., eds. Topics in dosimetry & treatment planning for neutron capture therapy. Madison, WI: Advanced Medical Publishing; 1994.